Sort
15,273 grants matching “antimicrobial resistance”
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$613,109Molly A Hughes · University Of Virginia · R01 · FY2023 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea
$612,866Cynthia Nau Cornelissen · Georgia State University · R01 · FY2019 · AI
Design and mechanistic studies of mimics of antimicrobial peptides
$612,144William F Degrado · University Of Pennsylvania · R01 · FY2010 · AI
The roles of genes critical for growth under defined conditions in vitro or duri
$612,109Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2013 · AI
Determinants of H. influenzae Virulence in Otitis Media
$611,942Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · DC
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
$611,834Marjana Tomic-Canic · University Of Miami School Of Medicine · R01 · FY2025 · DK
BIOCHEMICAL BASIS OF DELAYED TYPE HYPERSENSITIVITY
$611,604Harvard University (Sch Of Public Hlth) · R01 · FY2003 · AI
Cathelicidin in Skin Immunity
$611,296Richard L Gallo · University Of California, San Diego · R37 · FY2024 · AI
Precision targeting of T cell cytotoxicity with PET
$611,272Michael John Evans · University Of California, San Francisco · R01 · FY2024 · CA
The joint environment and periprosthetic joint infection
$611,177Noreen J Hickok · Thomas Jefferson University · R01 · FY2025 · AR
A mechanistic approach to intercalated cell phagocytosis
$611,115Andrew Lawrence Schwaderer · Indiana University Indianapolis · R01 · FY2025 · DK
Circadian Signatures in Chronic Lung Disease
$610,245Jeffrey Adam Haspel · Washington University · R01 · FY2022 · HL
A blind source separation approach for deconvolution of bulk transcriptional data leads to early detection of ATF cell-states in complex bacterial populations, in vitro and in vivo
$610,131Tim Van Opijnen · Broad Institute, Inc. · U19 · FY2022 · AI
Lactobacillus probiotic for prevention of recurrent UTI
$610,128Ann E Stapleton · University Of Washington · R01 · FY2012 · DK
Lactobacillus probiotic for prevention of recurrent UTI
$610,127Ann E Stapleton · University Of Washington · R01 · FY2014 · DK
Lactobacillus probiotic for prevention of recurrent UTI
$610,127Ann E Stapleton · University Of Washington · R01 · FY2015 · DK
Chicago Prevention and Intervention Epicenter (Chicago PIE)
$610,000Robert Alan Weinstein · Hektoen Institute For Medical Research · U54 · FY2014 · CK
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
$609,504David A Relman · Palo Alto Veterans Instit For Research · R01 · FY2020 · AI
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): POPULATION PHARMACOKINETICS STUDY
$609,231Patricia Winokur · University Of Iowa · N01 · FY2017 · AI
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
$608,986Jovanka M Voyich · Montana State University - Bozeman · R01 · FY2024 · AI
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
$608,986Jovanka M Voyich · Montana State University - Bozeman · R01 · FY2022 · AI
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
$608,986Jovanka M Voyich · Montana State University - Bozeman · R01 · FY2021 · AI
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
$608,986Jovanka M Voyich · Montana State University - Bozeman · R01 · FY2023 · AI
Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
$608,924Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faecium
$608,852Louis B. Rice · Rhode Island Hospital · R56 · FY2016 · AI